Abstract
Compartmental infectious disease models are used to calculate disease transmission, estimate underlying rates, forecast future burden, and compare benefits across intervention scenarios. These models aggregate individuals into compartments, often stratified by characteristics to represent groups that might be intervention targets or otherwise of particular concern. Ideally, model calculation could occur at the most demanding resolution for the overall analysis, but this may be infeasible due to availability of computational resources or empirical data. Instead, detailed population age-structure might be consolidated into broad categories such as children, working-age adults, and seniors. Researchers must then discretise key epidemic parameters, like the infection-fatality ratio, for these lower resolution groups. After estimating outcomes for those crude groups, follow on analyses, such as calculating years of life lost (YLLs), may need to distribute or weight those low-resolution outcomes back to the high resolution. The specific calculation for these aggregation and disaggregation steps can substantially influence outcomes.
To assist researchers with these tasks, we developed paramix, an R package which simplifies the transformations between high and low resolution. We demonstrate applying paramix to a common discretisation analysis: using age structured models for health economic calculations comparing YLLs. We compare how estimates vary between paramix and several alternatives for an archetypal model, including comparison to a high resolution benchmark. We consistently found that paramix yielded the most similar estimates to the high-resolution model, for the same computational burden of low-resolution models. In our illustrative analysis, the non-paramix methods estimated up to twice as many YLLs averted as the paramix approach, which would likely lead to a similarly large impact on incremental cost-effectiveness ratios used in economic evaluations.
Author summary Researchers use infectious disease models to understand trends in disease spread, including predicting future infections under different interventions. Constraints like data availability and numerical complexity drive researchers to group individuals into broad categories; for example, all working age adults might be represented as a single set of model compartments. Key epidemic parameters can vary widely across such groups. Additionally, model outcomes calculated using these broad categories often need to be disaggregated to a high resolution, for example a precise age at death for calculating years life lost, a key measure when estimating the cost-effectiveness of interventions. To satisfy these needs, we present a software package, paramix, which provides tools to move between high and low resolution data. In this paper, we demonstrate the capabilities of paramix by comparing various methods of calculating deaths and years of life lost across broad age groups. For an analysis of an archetypal model, we find paramix best matches a high-resolution model, while the alternatives are substantially different.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* cap1024{at}unc.edu
Abbreviations
- DALY
- Disability-Adjusted Life
- Year HIC
- High-Income Country
- IFR
- Infection-Fatality Ratio
- LMIC
- Low- and Middle-Income Country
- YLL
- Years of Life Lost
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.